13F Holdings
中文EN

Sanofi

Paris I0 · SEC CIK 0001121404

2026Q22026Q1 9 earlier quarters 🔒
$534.04M2026Q2 reported value
10Positions
100.0%Top 10 weight · largest 30.9%
0 / 1New / sold out
Reported value over time$534.04M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

MGTX 30.9%
INBX 20.5%
NVAX 12.1%
ANAB 10.4%
ODTX 7.0%
AGMB 6.8%
MPLT 6.1%
TRAX 3.1%
IMRX 2.5%
QTTB 0.6%

2026Q2 top buys estimated at quarter-end value

No buys this quarter

2026Q2 top sells estimated at quarter-end value

ELDN Sold out-$2.51M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
MGTX MeiraGTx Holdings plc $164.79M30.86%12,197,737 00.0% — Unchanged
INBX Inhibrx Biosciences, Inc. $109.71M20.54%1,157,926 00.0% — Unchanged
NVAX Novavax $64.81M12.14%6,880,481 00.0% — Unchanged
ANAB AnaptysBio $55.48M10.39%821,917 00.0% — Unchanged
ODTX Odyssey Therapeutics Inc. $37.27M6.98%1,991,918 1,991,918— — First reported
AGMB Agomab Therapeutics NV $36.12M6.76%2,783,096 00.0% — Unchanged
MPLT MapLight Therapeutics Inc. $32.69M6.12%912,041 00.0% — Unchanged
TRAX First Tracks Biotherapeutics Inc. $16.54M3.10%821,917 821,917— — First reported
IMRX Immuneering Corp $13.52M2.53%2,708,559 00.0% — Unchanged
QTTB Q32 Bio Inc. $3.11M0.58%244,083 00.0% — Unchanged
ELDN Eledon $00.00%0 -814,980-100.0% -$2.51M Sold out